Reportable Segment — Expenditures for long-lived assets
Business Segments · Expenditures for long-lived assetsEli Lilly Reportable Segment — Expenditures for long-lived assets increased by 22.9% to $2.85B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 74.4%, from $1.63B to $2.85B. Over 3 years (FY 2022 to FY 2025), Reportable Segment — Expenditures for long-lived assets shows an upward trend with a 55.9% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ4 2025
How to read this metric
High levels of expenditure suggest confidence in future demand and a commitment to expanding production capacity.
Detailed definition
Measures the capital invested by the segment into tangible or intangible assets expected to provide benefits over multip...
Peer comparison
Comparable to capital expenditures (CapEx) allocated to specific business segments in industrial and pharma sectors.
Metric ID:
lly_segment_reportable_segment_expenditures_for_long_lived_assetsHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $572.30M | $572.30M | $572.30M | $572.30M | $957.55M | $957.55M | $957.55M | $957.55M | $1.06B | $1.40B | $1.47B | $1.63B | $1.52B | $1.99B | $2.32B | $2.85B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +67.3% | +0.0% | +0.0% | +0.0% | +10.7% | +32.2% | +4.6% | +11.5% | -7.2% | +30.9% | +16.9% | +22.9% |
| YoY Change | — | — | — | — | +67.3% | +67.3% | +67.3% | +67.3% | +10.7% | +46.3% | +53.1% | +70.7% | +43.1% | +41.7% | +58.3% | +74.4% |
Range$572.30M – $2.85B
CAGR+53.4%
Avg YoY Growth+55.6%
Median YoY Growth+62.8%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's reportable segment — expenditures for long-lived assets?
- Eli Lilly (LLY) reported reportable segment — expenditures for long-lived assets of $2.85B in Q4 2025.
- How has Eli Lilly's reportable segment — expenditures for long-lived assets changed year-over-year?
- Eli Lilly's reportable segment — expenditures for long-lived assets increased by 74.4% year-over-year, from $1.63B to $2.85B.
- What is the long-term trend for Eli Lilly's reportable segment — expenditures for long-lived assets?
- Over 3 years (2022 to 2025), Eli Lilly's reportable segment — expenditures for long-lived assets has grown at a 55.9% compound annual growth rate (CAGR), from $2.29B to $8.67B.
- What does reportable segment — expenditures for long-lived assets mean?
- Capital spending on long-term assets like facilities and equipment for the segment.